Twist Bioscience Corp

TWST

$123.05

+106.8% (1 year change)

Market Cap

$5.82 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$53.81 - $214.07

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $5.82 Billion
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return +106.8%
52-Week High $214.07
52-Week Low $53.81
Beta 2.2
Outstanding Shares 48.9 Million
Avg 30 Day Volume 388 Thousand

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

Twist Bioscience Corp

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

News

Twist Bioscience Corp (TWST) CFO James M Thorburn Sold $598,750 of Shares

Twist Bioscience Corp (TWST) CFO James M Thorburn Sold $598,750 of Shares

Related Stocks: TWST ,

GuruFocus GuruFocus, 8 days ago
Gene Synthesis Market to Undertake Strapping Growth of 28.7% CAGR by the End 2025 with Leading Key Players: Integrated DNA Technologies, ATUM, Twist Bioscience, BioCat GmbH, OriGene Technologies, Inc., GENEWIZ

Gene Synthesis Market to Undertake Strapping Growth of 28.7% CAGR by the End 2025 with Leading Key Players: Integrated DNA Technologies, ATUM, Twist Bioscience, BioCat GmbH, OriGene Technologies, Inc., GENEWIZ

The Gene synthesis in healthcare market was valued at US$ 3,991.23 million in 2017 and it is projected to reach US$ 107,797.82 million by 2025; it is expected to grow at a CAGR of 28.7% from 2017 t...

OpenPR OpenPR, 10 days ago
Hedge Funds Keep Buying Twist Bioscience Corporation (TWST)

Hedge Funds Keep Buying Twist Bioscience Corporation (TWST)

No summary available.

Insider Monkey Insider Monkey, 13 days ago